European Archives - Page 582 of 1369 - European Medical Journal

New Immunotherapy Combinations for Patients with Oesophageal Cancer

Findings from a new Phase III study show promise for the dual approach of chemotherapy and immunotherapy as a first-line treatment for advanced oesophageal squamous cell carcinoma.

Predicting Brain Cancer Survival Using Artificial Intelligence

Researchers documented for the first time the use of AI predicting short- and long-term survival for adult patients with brain cancer after receiving radiotherapy. Read more.

Interview: Stephen Hoole

I was always fascinated by general medicine during my training as a medical student and house officer at the John Radcliffe Hospital…

Diabetes Medication Linked with Lower Risk of Kidney Stones

Lower risk of developing kidney stones has been associated with the use of SGLT2 inhibitors. These findings are critical, considering Type 2 diabetes is linked with a higher risk of developing kidney stones.

Exploring Circulating Tumour DNA as a Prognostic Tool in Colon Cancer

The NRG-GI005 (COBRA) Phase II/III study, the first of its kind, aimed to assess ctDNA clearance as a primary endpoint…

Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’

The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…

Inflammatory Bowel Disease Surgery Improves Patient-Reported Pain

Patients who underwent surgery for inflammatory bowel disease (IBD) reported better physical health 1 month after surgery, according to research. Read more.

Circulating Tumour DNA for Monitoring and Detecting Molecular Residual Disease

CtDNA may be used to detect molecular residual disease (MRD) in patients, and to monitor the effectiveness of treatment of patients…

The Burden of Respiratory Syncytial Virus and the Prevention of RSV Disease in Infants

Tune in for this latest podcast which considers the impact of respiratory syncytial virus (RSV) in infants and the importance of prevention strategies to mitigate the burden.

Anti-TNF Therapy Improves Growth Disturbances in Paediatric Crohn’s Disease

Anti-TNF therapy can lead to significant improvement in growth disturbances among children with Crohn’s disease: the number of patients with growth disturbances notably decreased 12 and 24 months after initiation of anti-TNF therapy.